| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $747.7M | -6.7% |
| Cost of Revenue | $380.0M | -2.1% |
| Gross Profit | $367.7M | -11.0% |
| R&D Expense | $169.7M | +22.0% |
| SG&A Expense | $352.5M | +5.0% |
| Operating Income | -$233.2M | -151.2% |
| Pre-tax Income | -$220.3M | -137.2% |
| Income Tax | $2.4M | +35.3% |
| Net Income | -$222.6M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $58.9M | -65.9% |
| Short-term Investments | $409.0M | -8.0% |
| Accounts Receivable | $105.6M | -8.0% |
| Inventory | $157.9M | +42.1% |
| Current Assets | $748.0M | -12.0% |
| Total Assets | $952.7M | -9.5% |
| Current Liabilities | $195.3M | +18.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$31.8M | -163.0% |
| Capital Expenditures | $26.8M | -21.4% |
| Investing Cash Flow | -$85.7M | -358.5% |
| Financing Cash Flow | $4.1M | -75.6% |
| Free Cash Flow | -$58.6M | -458.1% |
| -135.3% |
| EPS (Basic) | -$3.43 | -133.3% |
| EPS (Diluted) | -$3.43 | -133.3% |
| Total Liabilities |
| $639.0M |
| +4.3% |
| Stockholders' Equity | $313.6M | -28.7% |